Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Hello and welcome to the Summit ...

May is National Cancer Research Month. Join us in honoring the work being done to develop new cancer treatment options for ...

At the time, Cabanag’s family secured admission into an experimental bone marrow transplant protocol at the U.S. National ...

In the beginning of 2024, Smith said he had an ear ache, figuring it was an ear infection. His doctor gave him antibiotics, but the pain wouldn't go away. Smith described it running down into his jaw, ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas.

A Bay Area woman fights back against the odds to raise awareness about lung cancer in Asian American women who have never smoked.

Results from phase 2 trials appear to support the use of chemotherapy-free regimens in patients with osimertinib-resistant NSCLC.

Dr. Bryant Lin explains how his stage IV lung cancer diagnosis didn’t defeat him but instead inspired a revolutionary class.

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...